Literature DB >> 15189034

Progesterone receptor ligand binding pocket flexibility: crystal structures of the norethindrone and mometasone furoate complexes.

Kevin P Madauss1, Su-Jun Deng, Robert J H Austin, Millard H Lambert, Iain McLay, John Pritchard, Steven A Short, Eugene L Stewart, Ian J Uings, Shawn P Williams.   

Abstract

Although progesterone, the natural ligand of the progesterone receptor (PR), has a hydrogen atom at the 17alpha position, other potent steroid agonists such as norethindrone and mometasone furoate have larger substituents at this position that are accommodated by the PR ligand binding pocket. Crystallographic analysis of PR ligand binding domain complexes clearly demonstrated that these moieties were accommodated by local shifts of the protein main chain and by adoption of alternative side chain rotamer conformations of ligand-proximal amino acids. These conformational changes imparted a ligand-specific volume to the binding pocket, from 490 A3 in the metribolone complex to 520 A3 in the norethindrone complex, 565 A3 in the progesterone complex, and 730 A3 in the mometasone furoate complex. Despite these marked alterations in binding pocket volume, critical interactions essential for establishment of an active AF2 conformation were maintained.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189034     DOI: 10.1021/jm030640n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

1.  Deciphering modern glucocorticoid cross-pharmacology using ancestral corticosteroid receptors.

Authors:  Jeffrey A Kohn; Kirti Deshpande; Eric A Ortlund
Journal:  J Biol Chem       Date:  2012-03-21       Impact factor: 5.157

2.  Ultrafast protein structure-based virtual screening with Panther.

Authors:  Sanna P Niinivehmas; Kari Salokas; Sakari Lätti; Hannu Raunio; Olli T Pentikäinen
Journal:  J Comput Aided Mol Des       Date:  2015-09-25       Impact factor: 3.686

3.  Synthesis and evaluation of 17α-(dimethylphenyl)vinyl estradiols as probes of the estrogen receptor-α ligand binding domain.

Authors:  Robert N Hanson; Emmett McCaskill; Pakamas Tongcharoensirikul; Robert Dilis; David Labaree; Richard B Hochberg
Journal:  Steroids       Date:  2012-01-17       Impact factor: 2.668

4.  X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroids.

Authors:  Scott J Lusher; Hans C A Raaijmakers; Diep Vu-Pham; Bert Kazemier; Rolien Bosch; Ross McGuire; Rita Azevedo; Hans Hamersma; Koen Dechering; Arthur Oubrie; Marcel van Duin; Jacob de Vlieg
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

5.  Structural plasticity in the oestrogen receptor ligand-binding domain.

Authors:  Kendall W Nettles; John B Bruning; German Gil; Erin E O'Neill; Jason Nowak; Yuee Guo; Alun Hughs; Younchang Kim; Eugene R DeSombre; Robert Dilis; Robert N Hanson; Andrzej Joachimiak; Geoffrey L Greene
Journal:  EMBO Rep       Date:  2007-04-27       Impact factor: 8.807

6.  Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators.

Authors:  Scott J Lusher; Hans C A Raaijmakers; Diep Vu-Pham; Koen Dechering; Tsang Wai Lam; Angus R Brown; Niall M Hamilton; Olaf Nimz; Rolien Bosch; Ross McGuire; Arthur Oubrie; Jacob de Vlieg
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

7.  Synthesis and biological evaluation of water-soluble progesterone-conjugated probes for magnetic resonance imaging of hormone related cancers.

Authors:  Preeti A Sukerkar; Keith W MacRenaris; Taryn R Townsend; Roshan A Ahmed; Joanna E Burdette; Thomas J Meade
Journal:  Bioconjug Chem       Date:  2011-10-05       Impact factor: 4.774

8.  Effect of glucocorticoid-induced insulin resistance on follicle development and ovulation.

Authors:  Katherine S Hackbart; Pauline M Cunha; Rudelle K Meyer; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2013-06-20       Impact factor: 4.285

9.  The X-ray structure of RU486 bound to the progesterone receptor in a destabilized agonistic conformation.

Authors:  Hans C A Raaijmakers; Judith E Versteegh; Joost C M Uitdehaag
Journal:  J Biol Chem       Date:  2009-04-16       Impact factor: 5.157

10.  A new strategy for selective targeting of progesterone receptor with passive antagonists.

Authors:  Junaid A Khan; Abdellatif Tikad; Michel Fay; Abdallah Hamze; Jérôme Fagart; Nathalie Chabbert-Buffet; Geri Meduri; Larbi Amazit; Jean-Daniel Brion; Mouad Alami; Marc Lombès; Hugues Loosfelt; Marie-Edith Rafestin-Oblin
Journal:  Mol Endocrinol       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.